Next Article in Journal
PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
Previous Article in Journal
Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia
Previous Article in Special Issue
Proteomics and Drug Repurposing in CLL towards Precision Medicine
 
 
Article

Article Versions Notes

Cancers 2021, 13(18), 4518; https://doi.org/10.3390/cancers13184518
Action Date Notes Link
article xml file uploaded 8 September 2021 13:08 CEST Original file -
article xml uploaded. 8 September 2021 13:08 CEST Update https://www.mdpi.com/2072-6694/13/18/4518/xml
article pdf uploaded. 8 September 2021 13:08 CEST Version of Record https://www.mdpi.com/2072-6694/13/18/4518/pdf
article supplementary file uploaded. 8 September 2021 13:08 CEST - https://www.mdpi.com/2072-6694/13/18/4518#supplementary
article html file updated 8 September 2021 13:10 CEST Original file -
article html file updated 30 July 2022 04:51 CEST Update https://www.mdpi.com/2072-6694/13/18/4518/html
Back to TopTop